Trans-Synaptic Spread of Amyloid-β in Alzheimer's Disease: Paths to β-Amyloidosis

被引:20
|
作者
Pignataro, Annabella [1 ]
Middei, Silvia [1 ,2 ]
机构
[1] Santa Lucia Fdn, Lab Psychobiol, Dept Expt Neurol, Via Fosso Fiorano, I-00143 Rome, Italy
[2] Natl Res Ctr, Inst Cell Biol & Neurobiol, Via E Ramarini, I-00040 Rome, Italy
关键词
A-BETA; FUNCTIONAL CONNECTIVITY; REGIONAL VULNERABILITY; AEROBIC GLYCOLYSIS; DEFAULT NETWORK; BRAIN ACTIVITY; LONG-TERM; DEPOSITION; PROTEIN; APP;
D O I
10.1155/2017/5281829
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuronal activity has a strong causal role in the production and release of the neurotoxic beta-amyloid peptide (A beta). Because of this close link, gradual accumulation of A beta into amyloid plaques has been reported in brain areas with intense neuronal activity, including cortical regions that display elevated activation at resting state. However, the link between A beta and activity is not always linear and recent studies report exceptions to the view of "more activity, more plaques." Here, we review the literature about the activity-dependent production of A beta in both human cases and AD models and focus on the evidences that brain regions with elevated convergence of synaptic connections (herein referred to as brain nodes) are particularly vulnerable to A beta accumulation. Next, we will examine data supporting the hypothesis that, since A beta is released from synaptic terminals, beta-amyloidosis can spread in AD brain by advancing through synaptically connected regions, which makes brain nodes vulnerable to A beta accumulation. Finally, we consider possible mechanisms that account for beta-amyloidosis progression through synaptically linked regions.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Metals and amyloid-β in Alzheimer's disease
    Maynard, CJ
    Bush, AI
    Masters, CL
    Cappai, R
    Li, QX
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 147 - 159
  • [22] Alzheimer's Disease and the Amyloid-β Peptide
    Murphy, M. Paul
    LeVine, Harry, III
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 311 - 323
  • [23] Amyloid-β immunisation for Alzheimer's disease
    Wisniewski, Thomas
    Konietzko, Uwe
    LANCET NEUROLOGY, 2008, 7 (09): : 805 - 811
  • [24] Intracellular amyloid-β in Alzheimer's disease
    Frank M. LaFerla
    Kim N. Green
    Salvatore Oddo
    Nature Reviews Neuroscience, 2007, 8 : 499 - 509
  • [25] Autoantibodies to amyloid-β and Alzheimer's disease
    Hyman, BT
    Smith, C
    Buldyrev, I
    Whelan, C
    Brown, H
    Tang, MX
    Mayeux, R
    ANNALS OF NEUROLOGY, 2001, 49 (06) : 808 - 810
  • [26] Presenilins, amyloid-β and Alzheimer's disease
    Bruce T. Lamb
    Nature Medicine, 1997, 3 : 28 - 29
  • [27] Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
    Reddy, P. Hemachandra
    Manczak, Maria
    Mao, Peizhong
    Calkins, Marcus J.
    Reddy, Arubala P.
    Shirendeb, Ulziibat
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S499 - S512
  • [28] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Saido, TC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 51P - 51P
  • [29] Inhibition of Amyloid-β Aggregation in Alzheimer's Disease
    Wang, Qiuming
    Yu, Xiang
    Li, Lingyan
    Zheng, Jie
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (08) : 1223 - 1243
  • [30] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Higuchi, M
    Saido, TC
    PHARMACOLOGY & THERAPEUTICS, 2005, 108 (02) : 129 - 148